{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:33:49Z","timestamp":1786991629548,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de S\u00e3o Paulo (FAPESP)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jchromb.2015.12.049","type":"journal-article","created":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T11:47:05Z","timestamp":1451303225000},"page":"53-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study"],"prefix":"10.1016","volume":"1011","author":[{"given":"Francine Atti\u00e9","family":"de Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel dos Santos","family":"Scatena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ot\u00e1vio Pelegrino","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paula","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qu\u00e9zia Bezerra","family":"Cass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda Pinto","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera Lucia","family":"Lanchote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2015.12.049_bib0005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00003088-200038040-00001","article-title":"Metabolism and pharmacokinetics of oxazaphosphorines","volume":"38","author":"Boddy","year":"2000","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/clpt.2009.27","article-title":"Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy","volume":"85","author":"McCune","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.clpt.2005.05.005","article-title":"Metabolism-based cyclophosphamide dosing for hematopoietic cell transplant","volume":"78","author":"McDonald","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0020","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood-2002-06-1860","article-title":"Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation","volume":"101","author":"McDonald","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jchromb.2015.12.049_bib0025","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/sj.bjc.6603097","article-title":"High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy","volume":"94","author":"de Jonge","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jchromb.2015.12.049_bib0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1529-8019.2002.01540.x","article-title":"Alkylating agents","volume":"15","author":"Germanas","year":"2002","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0035","first-page":"2762","article-title":"Comparative metabolism of 2-[bis(2-chloroethyl)amino]tetrahydro-2-H-1,3,2-oxazaphosphorine-2-oxide (cyclophosphamide) and its enantiomers in humans","volume":"39","author":"Jarman","year":"1979","journal-title":"Cancer Res."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bmt.1703815","article-title":"Alteration of pharmacokinetics of cyclophosphamide and suppression of the cytochrome p450 genes by ciprofloxacin","volume":"31","author":"Xie","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0045","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1200\/JCO.1996.14.5.1484","article-title":"Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients","volume":"14","author":"Slattery","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0050","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1081\/JLC-100100448","article-title":"High performance liquid chromatographic determination of the stabilized cyclophosphamide metabolite 4-hydroxycyclophosphamide in plasma and red blood cells","volume":"23","author":"Huitema","year":"2000","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0378-4347(00)82616-X","article-title":"Analysis of 4-hydroxycyclophosphamide by gas chromatography\u2013mass spectrometry in plasma","volume":"495","author":"Hong","year":"1989","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0378-4347(95)00036-I","article-title":"Quantitation of 4-hydroxycyclophosphamide\/aldophosphamide in whole blood","volume":"667","author":"Anderson","year":"1995","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0065","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0378-4347(99)00178-4","article-title":"Determination of cyclophosphamide and its metabolites in human plasma by high-performance liquid chromatography\u2013mass spectrometry","volume":"729","author":"Baumann","year":"1999","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jchromb.2006.03.022","article-title":"Rapid quantitation of cyclophosphamide metabolites in plasma by liquid chromatography\u2013mass spectrometry","volume":"835","author":"Kalhorn","year":"2006","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed Life Sci."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0075","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/(SICI)1520-636X(1998)10:7<573::AID-CHIR4>3.0.CO;2-3","article-title":"Preparative enantioseparation on polysaccharide phase using microporous silica as a support","volume":"10","author":"Tiritan","year":"1998","journal-title":"Chirality"},{"key":"10.1016\/j.jchromb.2015.12.049_bib0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1520-636X(1996)8:1<147::AID-CHIR22>3.0.CO;2-M","article-title":"Enantiomeric resolution of chiral sulfoxides on polysaccharide phases by HPLC","volume":"8","author":"Matlin","year":"1996","journal-title":"Chirality"},{"key":"10.1016\/j.jchromb.2015.12.049_bib0085","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1021\/ja00456a044","article-title":"Absolute configuration of (+)-cyclophosphamide. A crystal and molecular structure determination by X-ray diffraction","volume":"99","author":"Karle","year":"1977","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0090","unstructured":"Guidance for Industry Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville (2001) http:\/\/www.fda.gov\/cder\/guidance."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0095","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00280-011-1554-7","article-title":"Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer","volume":"68","author":"Fernandes","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jchromb.2014.09.008","article-title":"Analysis of cyclophosphamide and carboxyethylphosphoramide mustard enantiomers in human plasma and application to clinical pharmacokinetics","volume":"971","author":"Atti\u00e9 de Castro","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2015.12.049_bib0105","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/0091270009337938","article-title":"Influence of glomerular filtration rate on the pharmacokinetics of cyclophosphamide enantiomers in patients with lupus nephritis","volume":"49","author":"de Miranda Silva","year":"2009","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jchromb.2007.04.024","article-title":"Simultaneous quantification of cyclophosphamide and its active metabolite 4-hydroxycyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (LC\u2013MS\/MS)","volume":"854","author":"Ekhart","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed Life Sci."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0115","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0378-4347(94)00462-E","article-title":"Measurement of 4-hydroxycyclophosphamide in serum by reversed-phase high-performance liquid chromatography","volume":"663","author":"Belfayol","year":"1995","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.jchromb.2015.12.049_bib0120","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0009-9236(98)90178-3","article-title":"Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients","volume":"64","author":"Ren","year":"1998","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023215303743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023215303743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T11:22:34Z","timestamp":1537096954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023215303743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":24,"alternative-id":["S1570023215303743"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2015.12.049","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2015.12.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}